About Us


PARC is a transdisciplinary research center focused on developing and testing new approaches for treating pain and addiction, decreasing the negative consequences of opioids, and developing effective ways to mitigate the impact of drugs of addiction.  It aims to provide a unified response to two major public health challenges:   

Chronic pain: a disabling condition that affects tens of millions of people in the US. Its impact on the health and well-being of the country is staggering, with a financial burden in excess of the costs of heart disease, cancer, and diabetes combined. It is essential to have a more informed clinical team with innovative evidence-based therapies to manage the care of patients with intractable pain.

Addiction: Opioids play a crucial role in the management of acute (postoperative) and cancer pain, as well as end-of-life care.  Although helpful for selected patients, overprescription of opioids has the potential to lead to misuse, diversion, use of other drugs of abuse and overdose. We must find ways to reduce the addictive potential of analgesic medications.

Our Response

As pain and addiction are often intertwined, PARC is committed to responding to these challenges through the development of team science working groups, seminars, retreats, and international symposia that cross boundaries and unite clinicians and scientists for common goals. Our working groups are currently focused on addressing the treatment of patients with pain and opioid use disorder drawing from PARC members with expertise in five thematic areas:  Prevention and Treatment; Education; Disparities; Pediatrics; and Cancer Pain. Please consider joining PARC.  


PARC is led by Director, Dr. Mark Schumacher, MD, PhD, Professor and Chief, Division of Pain Medicine, Department of Anesthesia and Perioperative Care, and Co-Director, Dr. Christine Miaskowski, RN, PhD, FAAN, Professor, Department of Physiological Nursing.                       

Core leadership from the Schools of Dentistry and Pharmacy is provided by Dr. Jon Levine, MD, PhD, Professor, Oral & Maxillofacial Surgery, and Dr. Lisa Kroon, PharmD, Professor and Chair of the Department of Clinical Pharmacy.   

Executive Sponsorship is provided by Dr. Michael Gropper, MD, PhD, Professor and Chair of the Department of Anesthesia and Perioperative Care.                    

The PARC Strategic Advisory Board is directed by Dr. Howard Fields, MD, PhD, Professor Emeritus, UCSF Weill Institute for Neurosciences.